𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Telomerase: A potential molecular marker and therapeutic target for cancer

✍ Scribed by Joe Y. Chang

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
50 KB
Volume
87
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Sirtuin-3 (SIRT3), a novel potential the
Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer
✍ Turki Y. Alhazzazi; Pachiyappan Kamarajan; Nam Joo; Jing-Yi Huang; Eric Verdin; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 455 KB

## BACKGROUND Several sirtuin family members (SIRT1-7), which are evolutionarily conserved NAD-dependent deacetylases, play an important role in carcinogenesis. However, their role in oral cancer has not yet been investigated. Therefore, the objective of this study was to investigate whether sirtui

Wnt/Ξ²-catenin-pathway as a molecular tar
Wnt/Ξ²-catenin-pathway as a molecular target for future anti-cancer therapeutics
✍ Susanne Dihlmann; Magnus von Knebel Doeberitz πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 213 KB

Conventional chemotherapeutic drugs used for the treatment of cancer patients in advanced stages have yielded only limited benefit, regarding survival time not to mention cure of the patients. To improve the clinical outcome of cancer, agents aimed at novel molecular targets are required. Colorectal

TGFΞ²R2 aberrant methylation is a potenti
TGFΞ²R2 aberrant methylation is a potential prognostic marker and therapeutic target in multiple myeloma
✍ FabrΓ­cio de Carvalho; Gisele W. B. Colleoni; Manuella S. Sampaio Almeida; AndrΓ© πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 108 KB

## Abstract Multiple myeloma (MM) is an incurable hematological malignancy. Different studies demonstrated the occurrence of genetic and epigenetic alterations in MM. The aberrant methylation is one of the most frequent epigenetic alterations in human genome. This study evaluated the aberrant methy